Highlights from the SWG

Research activities:

The MATTER Study: “Antithrombotic management patterns and outcomes in patients with hematological malignancy and thrombocytopenia: a Prospective Registry”. This is a multinational prospective Registry (Italy, Israel, Holland) of patients with hematological malignancies with thrombocytopenia and concurrent anti-thrombotic therapy in order to evaluate management strategies and frequency of thrombotic and bleeding outcomes.